Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
Authors
Keywords
DNA vaccination, Pseudomonas aeruginosa, Mouse models, Exotoxins, Secretion systems, Vaccines, Pseudomonas infections, Cytokines
Journal
PLoS One
Volume 9, Issue 5, Pages e96609
Publisher
Public Library of Science (PLoS)
Online
2014-05-02
DOI
10.1371/journal.pone.0096609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-κB1, STAT3, and CD40/CD154
- (2013) Denada Dibra et al. Cell Communication and Signaling
- Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
- (2013) Marlies Galle et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- IL-10-Producing Lymphocytes in Inflammatory Disease
- (2013) Yang Yao et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Technologies for enhanced efficacy of DNA vaccines
- (2012) Fadi Saade et al. Expert Review of Vaccines
- Timing of Toll-Like Receptor 9 Agonist Administration in Pneumococcal Vaccination Impacts Both Humoral and Cellular Immune Responses as Well as Nasopharyngeal Colonization in Mice
- (2012) Katrine M. Jensen et al. INFECTION AND IMMUNITY
- The Pseudomonas aeruginosa Type III Secretion System Has an Exotoxin S/T/Y Independent Pathogenic Role during Acute Lung Infection
- (2012) Marlies Galle et al. PLoS One
- Regulation of ENaC-mediated alveolar fluid clearance by insulin via PI3K/Akt pathway in LPS-induced acute lung injury
- (2012) Wang Deng et al. RESPIRATORY RESEARCH
- CpG Oligodeoxynucleotide 1826 Enhances the Lewis Lung Cancer Response to Radiotherapy in Murine Tumor
- (2011) Sujuan Yuan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Recent developments for Pseudomonas vaccines
- (2011) Anurag Sharma et al. Human vaccines & immunotherapeutics
- Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a Significant Role in Death Due to Lung Infection
- (2011) Jeevan Jyot et al. JOURNAL OF INFECTIOUS DISEASES
- Virulence of an exotoxin A-deficient strain of Pseudomonas aeruginosa toward the silkworm, Bombyx mori
- (2011) Yuuka Chieda et al. MICROBIAL PATHOGENESIS
- Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice
- (2011) SriJayaprakash Babu Uppada et al. VACCINE
- Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
- (2011) Hiromi Sato et al. Frontiers in Microbiology
- CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model
- (2010) Tao Jiang et al. ANTIVIRAL RESEARCH
- DNA vaccines: an historical perspective and view to the future
- (2010) Margaret A. Liu IMMUNOLOGICAL REVIEWS
- Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
- (2010) Sophie Bleves et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Control of effector export by thePseudomonas aeruginosatype III secretion proteins PcrG and PcrV
- (2010) Pei-Chung Lee et al. MOLECULAR MICROBIOLOGY
- CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases
- (2009) Dennis M. Klinman et al. ADVANCED DRUG DELIVERY REVIEWS
- Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
- (2009) Jeffrey L. Veesenmeyer et al. CRITICAL CARE MEDICINE
- Role of Pseudomonas aeruginosa type III effectors in disease
- (2009) Joanne Engel et al. CURRENT OPINION IN MICROBIOLOGY
- A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
- (2009) E. T. Weimer et al. INFECTION AND IMMUNITY
- FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
- (2009) Dennis M. Klinman et al. VACCINE
- Pseudomonas exotoxin A: From virulence factor to anti-cancer agent
- (2008) Philipp Wolf et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Oligomerization of PcrV and LcrV, Protective Antigens ofPseudomonas aeruginosaandYersinia pestis
- (2008) Gébus Caroline et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started